Welcome to our dedicated page for Quantum SEC filings (Ticker: QMCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Quantum Corporation (NASDAQ: QMCO) SEC filings page provides direct access to the company’s regulatory disclosures, offering detailed insight into its financial condition, capital structure, governance, and data management business. As a Delaware corporation listed on the Nasdaq Global Market, Quantum files annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A, and registration statements such as Form S-1.
Through these filings, investors can review segment-level revenue details, cost structures, and non-GAAP reconciliations that Quantum discusses in its earnings releases. Forms 10-K and 10-Q typically include information on product, service and subscription, and royalty revenue, gross profit, operating expenses, cash flows, and risk factors related to its data management platform for unstructured data.
Quantum’s Form 8-K filings document material events such as the Transaction Agreement and subsequent closing of a debt exchange with Dialectic Technology SPV LLC, the issuance of senior secured convertible notes, changes to its term loan facility, the grant of a Forbearance Warrant, and the appointment of CohnReznick LLP as independent registered public accounting firm. Other 8-Ks cover preliminary and final quarterly financial results, Nasdaq compliance updates, and the establishment of annual meeting dates.
The company’s DEF 14A proxy statements describe board composition, director elections, executive compensation, equity incentive plans, and shareholder proposals, while the S-1 registration statement filed in November 2025 outlines the resale of common stock issuable under the Forbearance Warrant and provides additional background on Quantum’s unstructured data and AI-focused business.
On this page, Stock Titan surfaces Quantum’s latest SEC filings as they are made available on EDGAR and enhances them with AI-powered summaries. These summaries are intended to highlight key points from lengthy documents—such as major financing terms, covenant changes, or governance proposals—so readers can more quickly understand the implications of 10-Ks, 10-Qs, 8-Ks, S-1s, and proxy materials. Users can also examine insider-related information through ownership and warrant disclosures contained in these filings.
Quantum Corporation completed a major debt restructuring with Dialectic Technology SPV LLC. The company exchanged term loans for $54,718,114 of senior secured convertible notes bearing 10.00% pay-in-kind interest and maturing on December 18, 2028. The initial conversion price is $10.00 per share, with reset features that can adjust it down to no lower than $4.00 based on trading prices after closing.
If the notes were fully converted at $10.00 and Dialectic fully exercised its existing forbearance warrant, Dialectic would hold about 36.9% of Quantum’s common stock. The notes are secured by the same collateral as the prior term loans and include financial covenants, including minimum liquidity levels that rise from $3.75 million at the end of Q1 2026 to $7.5 million by Q4 2026 and thereafter.
Shareholders approved the convertible note exchanges, potential additional Dialectic funding, anti-dilution-related warrant issuances, a 1,400,000-share increase to the 2023 Long-Term Incentive Plan, executive compensation on an advisory basis, and the appointment of CohnReznick LLP as auditor.
Quantum Corporation is registering 2,653,308 shares of common stock for resale by Dialectic Technology SPV LLC, issuable upon exercise of a Forbearance Warrant. The warrant covers shares equal to 19.9% of the outstanding common stock as of the Transaction Agreement date, has a cash or net-share exercise feature at an exercise price of $8.81 per share, and is exercisable for seven years. Shares outstanding were 13,333,208 as of September 30, 2025.
The warrant was issued as consideration under a Fifteenth Amendment to a term loan, which defers cash interest for the quarters ending September 30 and December 31, 2025 while increasing the interest rate on the affected loans by 2.00%. Quantum will not receive proceeds from any resale of shares by the selling stockholder, but will receive cash if the warrant is exercised, which it plans to use for working capital, general corporate purposes and debt repayment. The selling stockholder also holds a right to require Quantum to repurchase the warrant for $20.0 million in specified events.
Quantum Corporation filed a resale registration statement covering up to 2,653,308 shares of common stock issuable upon exercise of a warrant held by Dialectic Technology SPV LLC. The warrant, issued as consideration for amendments and forbearance under Quantum’s term loan agreement, has a cash or net-share exercise feature, a $8.81 exercise price and a seven-year term, and represents 19.9% of shares outstanding on the transaction date. Quantum will not receive proceeds from any resale of shares by the selling stockholder, but will receive cash if the warrant is exercised for cash, which it may use for working capital, general corporate purposes and debt repayment. Quantum had 13,333,208 shares of common stock outstanding as of September 30, 2025.
Quantum Corporation (QMCO) filed its 10-Q reporting a weaker quarter. Revenue was $62.7 million, down from $71.8 million a year ago, as product and service lines both declined. Gross margin fell to 37.6% from 42.7%.
The company posted a net loss of $46.5 million versus $12.2 million last year, driven by a $33.3 million loss on debt extinguishment and $3.2 million in restructuring charges. Cash and cash equivalents were $14.7 million, with total current liabilities of $241.7 million and a stockholders’ deficit of $160.5 million. Remaining performance obligations totaled $130.3 million, providing contracted revenue visibility.
Liquidity and capital structure updates: management disclosed substantial doubt about the ability to continue as a going concern. On September 23, 2025, Quantum agreed to exchange Dialectic’s term loans for senior secured convertible notes, subject to stockholder approval, and issued a forbearance warrant covering up to 2,653,308 shares at an $8.81 exercise price. The PNC credit facility was terminated on August 13, 2025. Under its $200 million SEPA, Quantum issued about 7.5 million shares for $82.8 million in net proceeds as of September 30, 2025.
Quantum Corporation reported financial results for the fiscal quarter ended September 30, 2025 and furnished the accompanying earnings press release as Exhibit 99.1 in a Form 8-K.
The information was provided under Item 2.02 and is expressly furnished, not filed under the Exchange Act, and will not be incorporated by reference into Securities Act filings. The company also listed Exhibit 104 for the cover page interactive data file.
Quantum Corporation (QMCO) reported an insider transaction on Form 4: a director received a grant of 1,000 restricted stock units (RSUs) on 11/01/2025 at a stated price of $0 per unit.
The RSUs vest in full on the earlier of November 1, 2026 or the date of the company’s next annual stockholder meeting, subject to continued board service. Following the grant, beneficial ownership stands at 1,000 common shares, held directly.
Quantum Corporation (QMCO)1,000 shares of common stock via a restricted stock unit (RSU) grant on November 1, 2025 at a stated price of $0.
The RSUs vest in full on the earlier of November 1, 2026 or the date of the company’s next annual stockholder meeting, contingent on continued service on the Board. Following the transaction, the reporting person beneficially owned 1,000 shares, held directly.
Quantum Corporation (QMCO) reported an insider equity grant. President & CEO and Director Hugues Meyrath acquired 37,500 shares of common stock via RSUs at $0 on 11/01/2025. He was also granted an employee stock option for 50,000 shares at an exercise price of $9.44.
The RSUs vest in four equal annual installments beginning July 1, 2026 (vesting commencement date July 1, 2025). The stock option vests on the same four-annual-installment schedule starting July 1, 2026. After these transactions, 62,200 common shares were beneficially owned directly, and 50,000 options were held.